A citation-based method for searching scientific literature

Melina Arnold, Jacques Ferlay, Mark I van Berge Henegouwen, Isabelle Soerjomataram. Gut 2020
Times Cited: 68







List of co-cited articles
312 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
26

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
26


Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
F Lordick, C Mariette, K Haustermans, R Obermannová, D Arnold. Ann Oncol 2016
466
13

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.
Yung-Jue Bang, Eric Van Cutsem, Andrea Feyereislova, Hyun C Chung, Lin Shen, Akira Sawaki, Florian Lordick, Atsushi Ohtsu, Yasushi Omuro, Taroh Satoh,[...]. Lancet 2010
13

Preoperative chemoradiotherapy for esophageal or junctional cancer.
P van Hagen, M C C M Hulshof, J J B van Lanschot, E W Steyerberg, M I van Berge Henegouwen, B P L Wijnhoven, D J Richel, G A P Nieuwenhuijzen, G A P Hospers, J J Bonenkamp,[...]. N Engl J Med 2012
11

Oesophageal cancer.
Elizabeth C Smyth, Jesper Lagergren, Rebecca C Fitzgerald, Florian Lordick, Manish A Shah, Pernilla Lagergren, David Cunningham. Nat Rev Dis Primers 2017
341
10

Epidemiology of Esophageal Squamous Cell Carcinoma.
Christian C Abnet, Melina Arnold, Wen-Qiang Wei. Gastroenterology 2018
528
10

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.
David Cunningham, William H Allum, Sally P Stenning, Jeremy N Thompson, Cornelis J H Van de Velde, Marianne Nicolson, J Howard Scarffe, Fiona J Lofts, Stephen J Falk, Timothy J Iveson,[...]. N Engl J Med 2006
10

Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial.
Ken Kato, Byoung Chul Cho, Masanobu Takahashi, Morihito Okada, Chen-Yuan Lin, Keisho Chin, Shigenori Kadowaki, Myung-Ju Ahn, Yasuo Hamamoto, Yuichiro Doki,[...]. Lancet Oncol 2019
319
10


Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030.
Melina Arnold, Mathieu Laversanne, Linda Morris Brown, Susan S Devesa, Freddie Bray. Am J Gastroenterol 2017
152
8

Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer.
Takashi Kojima, Manish A Shah, Kei Muro, Eric Francois, Antoine Adenis, Chih-Hung Hsu, Toshihiko Doi, Toshikazu Moriwaki, Sung-Bae Kim, Se-Hoon Lee,[...]. J Clin Oncol 2020
190
8

Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial.
Rebecca C Fitzgerald, Massimiliano di Pietro, Maria O'Donovan, Roberta Maroni, Beth Muldrew, Irene Debiram-Beecham, Marcel Gehrung, Judith Offman, Monika Tripathi, Samuel G Smith,[...]. Lancet 2020
60
8

Long-Term Follow-Up of a Community Assignment, One-Time Endoscopic Screening Study of Esophageal Cancer in China.
Wen-Qiang Wei, Zhi-Feng Chen, Yu-Tong He, Hao Feng, Jun Hou, Dong-Mei Lin, Xin-Qing Li, Cui-Lan Guo, Shao-Sen Li, Guo-Qing Wang,[...]. J Clin Oncol 2015
151
7

Global incidence of oesophageal cancer by histological subtype in 2012.
Melina Arnold, Isabelle Soerjomataram, Jacques Ferlay, David Forman. Gut 2015
741
7

The Epidemiology of Esophageal Adenocarcinoma.
Helen G Coleman, Shao-Hua Xie, Jesper Lagergren. Gastroenterology 2018
229
7

Reporting National Outcomes After Esophagectomy and Gastrectomy According to the Esophageal Complications Consensus Group (ECCG).
Leonie R van der Werf, Linde A D Busweiler, Johanna W van Sandick, Mark I van Berge Henegouwen, Bas P L Wijnhoven. Ann Surg 2020
58
8


Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study.
Jing Huang, Jianming Xu, Yun Chen, Wu Zhuang, Yiping Zhang, Zhendong Chen, Jia Chen, Helong Zhang, Zuoxing Niu, Qingxia Fan,[...]. Lancet Oncol 2020
109
7

Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis.
James K Y Hooi, Wan Ying Lai, Wee Khoon Ng, Michael M Y Suen, Fox E Underwood, Divine Tanyingoh, Peter Malfertheiner, David Y Graham, Vincent W S Wong, Justin C Y Wu,[...]. Gastroenterology 2017
915
5

Informing etiologic research priorities for squamous cell esophageal cancer in Africa: A review of setting-specific exposures to known and putative risk factors.
V A McCormack, D Menya, M O Munishi, C Dzamalala, N Gasmelseed, M Leon Roux, M Assefa, O Osano, M Watts, A O Mwasamwaja,[...]. Int J Cancer 2017
72
5

Implementation of Minimally Invasive Esophagectomy From a Randomized Controlled Trial Setting to National Practice.
Sheraz R Markar, Melody Ni, Suzanne S Gisbertz, Leonie van der Werf, Jennifer Straatman, Donald van der Peet, Miguel A Cuesta, George B Hanna, Mark I van Berge Henegouwen. J Clin Oncol 2020
28
14

Data verification of nationwide clinical quality registries.
L R van der Werf, S C Voeten, C M M van Loe, E G Karthaus, M W J M Wouters, H A Prins. BJS Open 2019
28
14

Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial.
Toshihiro Kudo, Yasuo Hamamoto, Ken Kato, Takashi Ura, Takashi Kojima, Takahiro Tsushima, Shuichi Hironaka, Hiroki Hara, Taroh Satoh, Satoru Iwasa,[...]. Lancet Oncol 2017
223
5

Benchmarking Complications Associated with Esophagectomy.
Donald E Low, Madhan Kumar Kuppusamy, Derek Alderson, Ivan Cecconello, Andrew C Chang, Gail Darling, Andrew Davies, Xavier Benoit D'Journo, Suzanne S Gisbertz, S Michael Griffin,[...]. Ann Surg 2019
243
5


Hot beverages and oesophageal cancer risk in western Kenya: Findings from the ESCCAPE case-control study.
Daniel Rs Middleton, Diana Menya, Nicholas Kigen, Margaret Oduor, Stephen K Maina, Fatma Some, David Chumba, Paul Ayuo, Odipo Osano, Joachim Schüz,[...]. Int J Cancer 2019
20
20


Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
Mohamed E Salem, Alberto Puccini, Joanne Xiu, Derek Raghavan, Heinz-Josef Lenz, W Michael Korn, Anthony F Shields, Philip A Philip, John L Marshall, Richard M Goldberg. Oncologist 2018
57
7

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial.
Kohei Shitara, Mustafa Özgüroğlu, Yung-Jue Bang, Maria Di Bartolomeo, Mario Mandalà, Min-Hee Ryu, Lorenzo Fornaro, Tomasz Olesiński, Christian Caglevic, Hyun C Chung,[...]. Lancet 2018
570
5

Endoscopic management of Barrett's esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement.
Bas Weusten, Raf Bisschops, Emanuel Coron, Mário Dinis-Ribeiro, Jean-Marc Dumonceau, José-Miguel Esteban, Cesare Hassan, Oliver Pech, Alessandro Repici, Jacques Bergman,[...]. Endoscopy 2017
219
5

A non-endoscopic device to sample the oesophageal microbiota: a case-control study.
Daffolyn R Fels Elliott, Alan W Walker, Maria O'Donovan, Julian Parkhill, Rebecca C Fitzgerald. Lancet Gastroenterol Hepatol 2017
66
6

Missing and decayed teeth, oral hygiene and dental staining in relation to esophageal cancer risk: ESCCAPE case-control study in Kilimanjaro, Tanzania.
Blandina T Mmbaga, Amos Mwasamwaja, Godfrey Mushi, Alex Mremi, Gissela Nyakunga, Ireen Kiwelu, Remigi Swai, Godwin Kiwelu, Sophia Mustapha, Eliawawomy Mghase,[...]. Int J Cancer 2020
10
40

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial.
Hansjochen Wilke, Kei Muro, Eric Van Cutsem, Sang-Cheul Oh, György Bodoky, Yasuhiro Shimada, Shuichi Hironaka, Naotoshi Sugimoto, Oleg Lipatov, Tae-You Kim,[...]. Lancet Oncol 2014
5

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.
Yelena Y Janjigian, Kohei Shitara, Markus Moehler, Marcelo Garrido, Pamela Salman, Lin Shen, Lucjan Wyrwicz, Kensei Yamaguchi, Tomasz Skoczylas, Arinilda Campos Bragagnoli,[...]. Lancet 2021
149
5

Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study.
Jong-Mu Sun, Lin Shen, Manish A Shah, Peter Enzinger, Antoine Adenis, Toshihiko Doi, Takashi Kojima, Jean-Philippe Metges, Zhigang Li, Sung-Bae Kim,[...]. Lancet 2021
57
7

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.
Ronan J Kelly, Jaffer A Ajani, Jaroslaw Kuzdzal, Thomas Zander, Eric Van Cutsem, Guillaume Piessen, Guillermo Mendez, Josephine Feliciano, Satoru Motoyama, Astrid Lièvre,[...]. N Engl J Med 2021
149
5

Multiplex H. pylori Serology and Risk of Gastric Cardia and Noncardia Adenocarcinomas.
Ramin Shakeri, Reza Malekzadeh, Dariush Nasrollahzadeh, Michael Pawlita, Gwen Murphy, Farhad Islami, Masoud Sotoudeh, Angelika Michel, Arash Etemadi, Tim Waterboer,[...]. Cancer Res 2015
30
10



Global time trends in the incidence of esophageal squamous cell carcinoma.
Qiao-Li Wang, Shao-Hua Xie, Karl Wahlin, Jesper Lagergren. Clin Epidemiol 2018
48
6

Recent developments in esophageal adenocarcinoma.
Jesper Lagergren, Pernilla Lagergren. CA Cancer J Clin 2013
197
4

Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experience.
Mariela Blum Murphy, Lianchum Xiao, Viren R Patel, Dipen M Maru, Arlene M Correa, Fatemeh G Amlashi, Zhongxing Liao, Ritsuko Komaki, Steven H Lin, Heath D Skinner,[...]. Cancer 2017
60
5


International Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy: Esophagectomy Complications Consensus Group (ECCG).
Donald E Low, Derek Alderson, Ivan Cecconello, Andrew C Chang, Gail E Darling, Xavier Benoit DʼJourno, S Michael Griffin, Arnulf H Hölscher, Wayne L Hofstetter, Blair A Jobe,[...]. Ann Surg 2015
468
4

Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study.
Jakob Manthey, Kevin D Shield, Margaret Rylett, Omer S M Hasan, Charlotte Probst, Jürgen Rehm. Lancet 2019
212
4

Individual and Combined Effects of Environmental Risk Factors for Esophageal Cancer Based on Results From the Golestan Cohort Study.
Mahdi Sheikh, Hossein Poustchi, Akram Pourshams, Arash Etemadi, Farhad Islami, Masoud Khoshnia, Abdolsamad Gharavi, Maryam Hashemian, Gholamreza Roshandel, Hooman Khademi,[...]. Gastroenterology 2019
59
5

Intrathoracic versus cervical anastomosis and predictors of anastomotic leakage after oesophagectomy for cancer.
J A H Gooszen, L Goense, S S Gisbertz, J P Ruurda, R van Hillegersberg, M I van Berge Henegouwen. Br J Surg 2018
59
5



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.